Tuberculosis (TB) Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Tuberculosis (TB) Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors Tuberculosis (TB) Diagnostics Market

The tuberculosis (TB) diagnostics market size was valued at USD 2.17 billion in 2023, and the market is now projected to grow from USD 2.28 billion in 2024 to USD 3.58 billion by 2032, exhibiting a CAGR of 5.8% during the forecast period of 2024-2032.

The COVID-19 pandemic prompted a decline in call for tuberculosis (TB) diagnostic products due to a extraordinary drop in affected person volumes for TB analysis and the diversion of property to combat the covid-19. However, in 2021 and 2022, the TB diagnostic marketplace skilled a huge rebound. As lockdown regulations have been lifted, TB trying out superior significantly, especially in excessive-burden international locations, essential to healing in the call for TB diagnostic products. This resurgence modified into pushed through the renewed recognition on addressing TB after the preliminary pandemic catastrophe.

Favorable government tips have surged the decision for tuberculosis (TB) diagnostics as a part of efforts to lessen the global TB burden. Increased awareness about the severity of the disease has pushed this call for, with many nations developing guidelines to enhance TB evaluation fees. Over the following few years, this fashion is expected to hold, appreciably boosting the decision for TB diagnostic merchandise. These responsibilities replicate an international willpower to enhancing public health results with the useful resource of addressing TB more successfully.

Increased public-non-public partnerships have drastically boosted marketplace increase thru increasing tuberculosis prognosis thru international healthcare necessities. In South Asia, the personal health quarter plays an essential position in imparting diagnostics for diseases like tuberculosis, supported by using authorities’ tasks. These partnerships, alongside government efforts to elevate attention about TB and sell early diagnosis, are expected to keep using marketplace increase in the coming years.

Comprehensive Analysis Tuberculosis (TB) Diagnostics Market

The tuberculosis (TB) diagnostic market growth is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessments considering the dominant supply and demand forces that impact the industry. These segmentations are methodically segregated by type analysis and by end-user. By type analysis include, culture-based diagnostics, sputum smear microscopy, rapid molecular diagnostics, and others. By end-user include, diagnostic laboratories and hospitals.

The North America region lead the tuberculosis (TB) diagnostics market share by benefitting a market size of USD 0.62 billion in 2023 due to rapid development of several end-use industries and the presence of key pharmaceutical manufacturers in the U.S the increasing prevalence of TB, which has been boosting the number of TB diagnosis being conducted in North America..

The top players in the market play a crucial role in the industry assuring market growth and setting market standards. These players include, F. Hoffmann-La Roche Ltd (Switzerland), bioMérieux SA (France), QIAGEN (Netherlands), BD (U.S.), Cepheid (Danaher) (U.S.), Thermo Fisher Scientific Inc. (U.S.), Abbott Laboratories (U.S.), Hologic, Inc. (U.S.), Hain Lifescience GmbH (Germany), Oxford Immunotec USA, Inc. (U.K.), these market players provide a level-playing competitive landscape.

In September 2023, QIAGEN donated 3000 QuantiFERON-TB Gold Plus exams to the Ministry of Health (MOH) Malaysia to resource in latent tuberculosis contamination (LTBI) screening for immunocompromised people.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 5.8% from 2024-2032

Unit Value (USD Billion)

Segmentation

By Type

Culture-based Diagnostics

Sputum Smear Microscopy

Rapid Molecular Diagnostics

Others

By End-user

Diagnostic Laboratories

Hospitals

By Region

North America (By Type, By End-user)

- U.S.

- Canada

Europe (By Type, By End-user)

- U.K.

- Germany

- France

- Italy

- Russia

- Nordic

- Rest of Europe

Asia Pacific (By Type, By End-user)

- China

- Japan

- South Korea

- Southeast Asia

- India

- Australia

- Rest of Asia Pacific

Latin America (By Type, By End-user)

- Brazil

- Mexico

- Rest of Latin America

Middle East & Africa (By Type, By End-user)

- GCC

- South Africa

- Rest of the Middle East & Africa


Please Note: It will take 5-6 business days to complete the report upon order confirmation.